German ethics commission disparages routine PND (prenatal diagnostics):
This article was originally published in Clinica
Executive Summary
Over the past two decades, prenatal diagnostics (PND) have become a routine procedure within the German health system. Dr Wolfgang Wodarg, the Social Democratic (SPD) speaker of the parliamentary "rights and ethics of modern medicine" commission believes that the rise could lead to genetic selection, particularly if in the future easily accessible DNA chips were to be made available. In 1976 the sickness funds agreed to reimburse PND and since then the number of procedures has risen from 1,796 in 1976 to 68,267 in 1997. Dr Wodarg acknowledges that the rise has come as a result of doctors' obligations to inform parents about cystic fibrosis and an increase in the demand for ultrasound scans by pregnant women. The problem is that if no ultrasound scan is carried out, then the doctor will not be able to claim reimbursement for assisting a pregnancy, as the sickness funds would say that he had not carried out the necessary procedures.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.